Chairman, Alliance for Regenerative Medicine (ARM); President, PCT, A Caladrius Company; SVP, Manufacturing and Technical Operations, Caladrius Biosciences
Dr. Preti is the co-Founder of PCT, a Caladrius company, an industry-leading cell therapy contract development and manufacturing organization, and the visionary behind its successful growth and development strategy over much of the last two decades. In addition to his roles at PCT and Caladrius Biosciences, he is also the Chairman for the Alliance for Regenerative Medicine. He has published and presented extensively on a variety of topics relating to cellular therapies and holds a B.S. in Biology from Fordham University, and an M.S. and doctorate from New York University.
The opening panel discussion will give an overview of the state of the gene therapy, cancer immunotherapy, and regenerative medicine fields. Alliance for Regenerative Medicine’s Chair, Dr. Robert Preti, will moderate the panel of industry and research experts.